Evidence map›Paper›PMID 26512901›Full record

ArticlePloS one2015

Gabapentin Effects on PKC-ERK1/2 Signaling in the Spinal Cord of Rats with Formalin-Induced Visceral Inflammatory Pain.

Yan-Bo Zhang, Zheng-Dong Guo, Mei-Yi Li, Peter Fong, Ji-Guo Zhang, Can-Wen Zhang, Ke-Rui Gong, Ming-Feng Yang, Jing-Zhong Niu, Xun-Ming Ji and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Yan-Bo ZhangDepartment of Neurology, Affiliated Hospital of Taishan Medical University, Taian, China.
Zheng-Dong GuoDepartment of Endocrinology, Affiliated Hospital of Taishan Medical University, Taian, China.
Mei-Yi LiDepartment of Neurology, Shandong Taishan Chronic Disease Hospital, Taian, China.
Peter FongDepartment of Neurology, University of California San Francisco, San Francisco, CA, United States of America.
Ji-Guo ZhangDepartment of Pharmacology, College of Pharmacy, Taishan Medical University, Taian, China.
Can-Wen ZhangDepartment of Neurology, Affiliated Hospital of Taishan Medical University, Taian, China.
Ke-Rui GongDepartment of Oral and Maxillofacial Surgery, University of California San Francisco, San Francisco, CA, United States of America.
Ming-Feng YangDepartment of Neurology, Affiliated Hospital of Taishan Medical University, Taian, China.
Jing-Zhong NiuDepartment of Neurology, Affiliated Hospital of Taishan Medical University, Taian, China.
Xun-Ming JiHypoxia Medical Institute, Xuanwu Hospital, Capital Medical University, Beijing, China.
Guo-Wei LvHypoxia Medical Institute, Xuanwu Hospital, Capital Medical University, Beijing, China.
Affiliated Hospital of Taishan Medical University · CNCapital Medical University · CNUniversity of California, San Francisco · USTaishan Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Currently, the clinical management of visceral pain remains unsatisfactory for many patients suffering from this disease. While preliminary animal studies have suggested the effectiveness of gabapentin in successfully treating visceral pain, the mechanism underlying its analgesic effect remains unclear. Evidence from other studies has demonstrated the involvement of protein kinase C (PKC) and extracellular signal-regulated kinase1/2 (ERK1/2) in the pathogenesis of visceral inflammatory pain. In this study, we tested the hypothesis that gabapentin produces analgesia for visceral inflammatory pain through its inhibitory effect on the PKC-ERK1/2 signaling pathway. Intracolonic injections of formalin were performed in rats to produce colitis pain. Our results showed that visceral pain behaviors in these rats decreased after intraperitoneal injection of gabapentin. These behaviors were also reduced by intrathecal injections of the PKC inhibitor, H-7, and the ERK1/2 inhibitor, PD98059. Neuronal firing of wide dynamic range neurons in L6-S1 of the rat spinal cord dorsal horn were significantly increased after intracolonic injection of formalin. This increased firing rate was inhibited by intraperitoneal injection of gabapentin and both the individual and combined intrathecal application of H-7 and PD98059. Western blot analysis also revealed that PKC membrane translocation and ERK1/2 phosphorylation increased significantly following formalin injection, confirming the recruitment of PKC and ERK1/2 during visceral inflammatory pain. These effects were also significantly reduced by intraperitoneal injection of gabapentin. Therefore, we concluded that the analgesic effect of gabapentin on visceral inflammatory pain is mediated through suppression of PKC and ERK1/2 signaling pathways. Furthermore, we found that the PKC inhibitor, H-7, significantly diminished ERK1/2 phosphorylation levels, implicating the involvement of PKC and ERK1/2 in the same signaling pathway. Thus, our results suggest a novel mechanism of gabapentin-mediated analgesia for visceral inflammatory pain through a PKC-ERK1/2 signaling pathway that may be a future therapeutic target for the treatment of visceral inflammatory pain.

Indexed as

1-(5-Isoquinolinesulfonyl)-2-MethylpiperazineAminesAnimalsBehavior, AnimalCell MembraneCyclohexanecarboxylic AcidsDisease Models, AnimalElectrophysiological PhenomenaFlavonoidsFormaldehydeGabapentingamma-Aminobutyric AcidMaleMAP Kinase Signaling SystemNeuronsPain Management1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-oneAminesCyclohexanecarboxylic AcidsFlavonoidsFormaldehydeGabapentingamma-Aminobutyric AcidProtein Kinase C

Identifiers

PMID26512901
PMCPMC4626203
OpenAlexW2208056949

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.